(2S)-2-[[(3S,6S,9S,12S,15R)-3-benzyl-9-[2-(4-hydroxyphenyl)ethyl]-6,7-dimethyl-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazacyclononadec-15-yl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 15%; R=17500; [M-H]-

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 180%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 30%; R=17500; [M-H]-

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 45%; R=17500; [M-H]-

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 60%; R=17500; [M-H]-

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 75%; R=17500; [M-H]-

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+

Anabaenopeptin B; LC-ESI-QFT; MS2; CE: 90%; R=17500; [M-H]-